Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC

Clinical trial NCT06613633 · COMPLETED

Trial details

NCT number: NCT06613633
Sponsor: Fudan University
Status: COMPLETED
Study type: OBSERVATIONAL

Third-generation TKI NSCLC (Advanced Non-small Cell Lung Cancer)

Start date: 2018-09-01
Primary completion: 2024-08-01
Enrollment: 4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.